Previous 10 | Next 10 |
Through the Company’s continued work with Curexo, its exclusive distribution partner for South Korea, Bionik will be featured as part of the show’s focus on the future of the medical industry Bionik Laboratories Corp . (OTCPINK: BNKL), a robotics company providing neur...
Bionik Laboratories press release ( OTCPK:BNKL ): Q3 Non-GAAP EPS of -$0.15. Revenue of $0.57M (+216.7% Y/Y). For further details see: Bionik Laboratories Non-GAAP EPS of -$0.15, revenue of $0.57M
Nine Month Shipments and Revenue Exceeds 12-month Results of Prior Fiscal Year Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technolo...
Bionik Laboratories press release ( OTCPK:BNKL ): Q2 GAAP EPS of -$0.16. Revenue of $0.49M (+113.0% Y/Y). For further details see: Bionik Laboratories GAAP EPS of -$0.16, revenue of $0.49M
Launch of Centers of Excellence Strategy Increases Outlook for Growth Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, today reported fin...
Presentation to be Webcast at 9:00 AM (ET), Monday, November 14, 2022 BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Bionik Laboratories Corp . (OTCPINK:BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recov...
Bionik Laboratories ( OTCPK:BNKL ) appoints Richard Russo, Jr. as CEO and President and Dan Gonsalves as CFO and executive VP. Richard Russo previously served as the CFO of the company and Dan Gonsalves was the company's Corporate Controller. Both appoi...
Company continues to ramp up its recently announced growth strategy featuring ‘Centers of Excellence’ for Neuro-Recovery Care to broaden access to robotic rehabilitation Bionik Laboratories Corp . (OTCPINK:BNKL) ("Bionik" or the "Company"), a robotics compa...
Company’s specialized Neuro-Recovery Care Centers to showcase Bionik technology and solutions Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others ...
Company focused on delivering long term value for investors BOSTON, MA / ACCESSWIRE / September 1, 2022 / BIONIK Laboratories Corp. (OTC PINK:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke survivors ...
News, Short Squeeze, Breakout and More Instantly...
Bionik Laboratories Corp Company Name:
BNKL Stock Symbol:
OTCMKTS Market:
Bionik Laboratories Corp Website:
Klepierre (KLPEF) is expected to report for Q1 2024 Amerityre Corp (AMTY) is expected to report for Q3 2024 Gecina Nom. (GECFF) is expected to report for Q1 2024 Great Eagle Holdings Limited (GEAHF) is expected to report for Q1 2024 Babylon Holdings Limited Class A (BBLNF) is expe...
Amerityre Corp (AMTY) is expected to report for Q3 2024 CURO Group Holdings Corp. (CUROQ) is expected to report for Q1 2024 China Health Industries Holdings Inc (CHHE) is expected to report for Q3 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Anterix In...
Blue Ridge Real Estate Co. (BRRE) is expected to report for Q2 2024 Aravive Inc. (ARAV) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Golden Matrix Group Inc. (GMGI) is expected to report for Q2 2024 Bluejay Diagnostics Inc. (BJDX) is exp...